{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:37:00Z","timestamp":1790267820100,"version":"4.1.0"},"reference-count":67,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The hormone erythroferrone (ERFE) is produced by erythroid cells in response to hemorrhage, hypoxia, or other erythropoietic stimuli, and it suppresses the hepatic production of the iron-regulatory hormone hepcidin, thereby mobilizing iron for erythropoiesis. Suppression of hepcidin by ERFE is believed to be mediated by interference with paracrine bone morphogenetic protein (BMP) signaling that regulates hepcidin transcription in hepatocytes. In anemias with ineffective erythropoiesis, ERFE is pathologically overproduced, but its contribution to the clinical manifestations of these anemias is not well understood. We generated 3 lines of transgenic mice with graded erythroid overexpression of ERFE and found that they developed dose-dependent iron overload, impaired hepatic BMP signaling, and relative hepcidin deficiency. These findings add to the evidence that ERFE is a mediator of iron overload in conditions in which ERFE is overproduced, including anemias with ineffective erythropoiesis. At the highest levels of ERFE overexpression, the mice manifested decreased perinatal survival, impaired growth, small hypofunctional kidneys, decreased gonadal fat depots, and neurobehavioral abnormalities, all consistent with impaired organ-specific BMP signaling during development. Neutralizing excessive ERFE in congenital anemias with ineffective erythropoiesis may not only prevent iron overload but may have additional benefits for growth and development.<\/jats:p>","DOI":"10.1182\/blood.2021014054","type":"journal-article","created":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T16:53:05Z","timestamp":1633539185000},"page":"439-451","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":34,"title":["Erythroid overproduction of erythroferrone causes iron overload and developmental abnormalities in mice"],"prefix":"10.1182","volume":"139","author":[{"given":"Richard","family":"Coffey","sequence":"first","affiliation":[{"name":"Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Olivera","sequence":"additional","affiliation":[{"name":"Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4662-0921","authenticated-orcid":false,"given":"Gabriel","family":"Karin","sequence":"additional","affiliation":[{"name":"Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata C.","family":"Pereira","sequence":"additional","affiliation":[{"name":"Department of Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3477-2397","authenticated-orcid":false,"given":"Elizabeta","family":"Nemeth","sequence":"additional","affiliation":[{"name":"Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2830-5469","authenticated-orcid":false,"given":"Tomas","family":"Ganz","sequence":"additional","affiliation":[{"name":"Department of Medicine,"},{"name":"Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5704","key":"2022012016251089600_B1","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science."},{"issue":"12","key":"2022012016251089600_B2","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1172\/JCI63924","article-title":"Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis","volume":"122","author":"Liu","year":"2012","journal-title":"J Clin Invest."},{"issue":"5","key":"2022012016251089600_B3","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1182\/blood-2014-10-606491","article-title":"Hepcidin is suppressed by erythropoiesis in hemoglobin E \u03b2-thalassemia and \u03b2-thalassemia trait","volume":"125","author":"Jones","year":"2015","journal-title":"Blood."},{"issue":"1","key":"2022012016251089600_B4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/pbc.20616","article-title":"Urinary hepcidin in congenital chronic anemias","volume":"48","author":"Kearney","year":"2007","journal-title":"Pediatr Blood Cancer."},{"issue":"12","key":"2022012016251089600_B5","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1182\/blood-2006-06-028787","article-title":"Suppression of hepcidin during anemia requires erythropoietic activity","volume":"108","author":"Pak","year":"2006","journal-title":"Blood."},{"issue":"7","key":"2022012016251089600_B6","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ng.2996","article-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism","volume":"46","author":"Kautz","year":"2014","journal-title":"Nat Genet."},{"issue":"14","key":"2022012016251089600_B7","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2018-06-857995","article-title":"Erythroferrone inhibits the induction of hepcidin by BMP6","volume":"132","author":"Arezes","year":"2018","journal-title":"Blood."},{"issue":"6","key":"2022012016251089600_B8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood.2019002620","article-title":"Erythroferrone lowers hepcidin by sequestering BMP2\/6 heterodimer from binding to the BMP type I receptor ALK3","volume":"135","author":"Wang","year":"2020","journal-title":"Blood."},{"issue":"4","key":"2022012016251089600_B9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood-2016-07-729822","article-title":"Angiocrine Bmp2 signaling in murine liver controls normal iron homeostasis","volume":"129","author":"Koch","year":"2017","journal-title":"Blood."},{"issue":"4","key":"2022012016251089600_B10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1182\/blood-2016-06-721571","article-title":"Endothelial cells produce bone morphogenetic protein 6 required for iron homeostasis in mice","volume":"129","author":"Canali","year":"2017","journal-title":"Blood."},{"issue":"8","key":"2022012016251089600_B11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1182\/blood.2019003140","article-title":"Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia","volume":"135","author":"Arezes","year":"2020","journal-title":"Blood."},{"issue":"10","key":"2022012016251089600_B12","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood-2017-04-777987","article-title":"Immunoassay for human serum erythroferrone","volume":"130","author":"Ganz","year":"2017","journal-title":"Blood."},{"issue":"4","key":"2022012016251089600_B13","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/jmri.21707","article-title":"Assessment of iron distribution between liver, spleen, pancreas, bone marrow, and myocardium by means of R2 relaxometry with MRI in patients with beta-thalassemia major","volume":"29","author":"Papakonstantinou","year":"2009","journal-title":"J Magn Reson Imaging."},{"issue":"8","key":"2022012016251089600_B14","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1681\/ASN.2011111070","article-title":"Mechanisms of renal disease in \u03b2-thalassemia","volume":"23","author":"Musallam","year":"2012","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"2022012016251089600_B15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2265.1995.tb02684.x","article-title":"Short stature in homozygous beta-thalassaemia is due to disproportionate truncal shortening","volume":"42","author":"Rodda","year":"1995","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"1","key":"2022012016251089600_B16","first-page":"29","article-title":"Bone mineral density in beta-thalassemia major and intermedia","volume":"44","author":"Karimi","year":"2007","journal-title":"Indian Pediatr."},{"issue":"16","key":"2022012016251089600_B17","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/blood-2014-06-584607","article-title":"Erythroferrone contributes to recovery from anemia of inflammation","volume":"124","author":"Kautz","year":"2014","journal-title":"Blood."},{"issue":"17","key":"2022012016251089600_B18","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood-2015-07-658419","article-title":"Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of \u03b2-thalassemia","volume":"126","author":"Kautz","year":"2015","journal-title":"Blood."},{"issue":"19","key":"2022012016251089600_B19","doi-asserted-by":"crossref","first-page":"e13890","DOI":"10.14814\/phy2.13890","article-title":"Erythroferrone is not required for the glucoregulatory and hematologic effects of chronic erythropoietin treatment in mice","volume":"6","author":"Coffey","year":"2018","journal-title":"Physiol Rep."},{"issue":"9","key":"2022012016251089600_B20","doi-asserted-by":"crossref","first-page":"e627","DOI":"10.1097\/HS9.0000000000000627","article-title":"A comprehensive analysis of the erythropoietin-erythroferrone-hepcidin pathway in hereditary hemolytic anemias","volume":"5","author":"van Vuren","year":"2021","journal-title":"HemaSphere."},{"key":"2022012016251089600_B21","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3389\/fphys.2019.01534","article-title":"The many facets of erythropoietin physiologic and metabolic response","volume":"10","author":"Suresh","year":"2020","journal-title":"Front Physiol."},{"issue":"1","key":"2022012016251089600_B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gene.20020","article-title":"Transgenic Cre expression mice for generation of erythroid-specific gene alterations","volume":"39","author":"Peterson","year":"2004","journal-title":"Genesis."},{"issue":"2","key":"2022012016251089600_B23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bcmd.2003.11.003","article-title":"Strain and gender modulate hepatic hepcidin 1 and 2 mRNA expression in mice","volume":"32","author":"Courselaud","year":"2004","journal-title":"Blood Cells Mol Dis."},{"issue":"4","key":"2022012016251089600_B24","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.24178","article-title":"Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice","volume":"53","author":"Ramos","year":"2011","journal-title":"Hepatology."},{"issue":"1","key":"2022012016251089600_B25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.24359","article-title":"Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in mice","volume":"54","author":"Corradini","year":"2011","journal-title":"Hepatology."},{"issue":"1","key":"2022012016251089600_B26","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.kint.2018.08.028","article-title":"Canonical BMP signaling in tubular cells mediates recovery after acute kidney injury","volume":"95","author":"Vigolo","year":"2019","journal-title":"Kidney Int."},{"issue":"26","key":"2022012016251089600_B27","doi-asserted-by":"crossref","first-page":"27560","DOI":"10.1074\/jbc.M404222200","article-title":"Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling","volume":"279","author":"Mishina","year":"2004","journal-title":"J Biol Chem."},{"issue":"12","key":"2022012016251089600_B28","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/ng1916","article-title":"BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing","volume":"38","author":"Tsuji","year":"2006","journal-title":"Nat Genet."},{"issue":"12","key":"2022012016251089600_B29","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1371\/journal.pgen.0020216","article-title":"Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis","volume":"2","author":"Bandyopadhyay","year":"2006","journal-title":"PLoS Genet."},{"issue":"11","key":"2022012016251089600_B30","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1182\/blood-2006-09-048868","article-title":"Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin","volume":"109","author":"Gardenghi","year":"2007","journal-title":"Blood."},{"issue":"10","key":"2022012016251089600_B31","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.3324\/haematol.2013.087114","article-title":"Investigation of the role of interleukin-6 and hepcidin antimicrobial peptide in the development of anemia with age","volume":"98","author":"McCranor","year":"2013","journal-title":"Haematologica."},{"issue":"3","key":"2022012016251089600_B32","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.3324\/haematol.2016.150433","article-title":"Increased serum hepcidin contributes to the anemia of chronic kidney disease in a murine model","volume":"102","author":"Hanudel","year":"2017","journal-title":"Haematologica."},{"issue":"12","key":"2022012016251089600_B33","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1172\/JCI41717","article-title":"Hepcidin as a therapeutic tool to limit iron overload and improve anemia in \u03b2-thalassemic mice","volume":"120","author":"Gardenghi","year":"2010","journal-title":"J Clin Invest."},{"issue":"2","key":"2022012016251089600_B34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2015-10-676742","article-title":"Minihepcidin peptides as disease modifiers in mice affected by \u03b2-thalassemia and polycythemia vera","volume":"128","author":"Casu","year":"2016","journal-title":"Blood."},{"issue":"11","key":"2022012016251089600_B35","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/ajh.25613","article-title":"The BMP-SMAD pathway mediates the impaired hepatic iron metabolism associated with the ERFE-A260S variant","volume":"94","author":"Andolfo","year":"2019","journal-title":"Am J Hematol."},{"issue":"7","key":"2022012016251089600_B36","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1074\/jbc.M111023200","article-title":"Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter","volume":"277","author":"Korchynskyi","year":"2002","journal-title":"J Biol Chem."},{"issue":"13","key":"2022012016251089600_B37","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1182\/blood-2009-09-238105","article-title":"SMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression","volume":"115","author":"Mleczko-Sanecka","year":"2010","journal-title":"Blood."},{"key":"2022012016251089600_B38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fphar.2014.00104","article-title":"Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis","volume":"5","author":"Core","year":"2014","journal-title":"Front Pharmacol."},{"issue":"36","key":"2022012016251089600_B39","doi-asserted-by":"crossref","first-page":"13292","DOI":"10.1074\/jbc.RA118.007213","article-title":"Hepatic heparan sulfate is a master regulator of hepcidin expression and iron homeostasis in human hepatocytes and mice","volume":"294","author":"Poli","year":"2019","journal-title":"J Biol Chem."},{"issue":"22","key":"2022012016251089600_B40","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1101\/gad.9.22.2795","article-title":"A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye","volume":"9","author":"Dudley","year":"1995","journal-title":"Genes Dev."},{"issue":"14","key":"2022012016251089600_B41","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1073\/pnas.0500031102","article-title":"Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in\u00a0vivo","volume":"102","author":"Yoon","year":"2005","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1-2","key":"2022012016251089600_B42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.heares.2006.12.010","article-title":"The role of bone morphogenetic protein 4 in inner ear development and function","volume":"225","author":"Blauwkamp","year":"2007","journal-title":"Hear Res."},{"issue":"2","key":"2022012016251089600_B43","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ydbio.2019.12.007","article-title":"The secreted BMP antagonist ERFE is required for the development of a functional circulatory system in Xenopus","volume":"459","author":"Melchert","year":"2020","journal-title":"Dev Biol."},{"issue":"1","key":"2022012016251089600_B44","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1749-6632.1996.tb56247.x","article-title":"BMP 7 is required for nephrogenesis, eye development, and skeletal patterning","volume":"785","author":"Karsenty","year":"1996","journal-title":"Ann N Y Acad Sci."},{"issue":"22","key":"2022012016251089600_B45","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1101\/gad.9.22.2808","article-title":"BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning","volume":"9","author":"Luo","year":"1995","journal-title":"Genes Dev."},{"issue":"5","key":"2022012016251089600_B46","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1242\/dev.01673","article-title":"Distinct developmental programs require different levels of Bmp signaling during mouse retinal development","volume":"132","author":"Murali","year":"2005","journal-title":"Development."},{"key":"2022012016251089600_B47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7554\/eLife.48872","article-title":"BMP7 functions predominantly as a heterodimer with BMP2 or BMP4 during mammalian embryogenesis","volume":"8","author":"Kim","year":"2019","journal-title":"eLife."},{"key":"2022012016251089600_B48","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.molmet.2019.04.004","article-title":"Noggin depletion in adipocytes promotes obesity in mice","volume":"25","author":"Bl\u00e1zquez-Medela","year":"2019","journal-title":"Mol Metab."},{"issue":"5","key":"2022012016251089600_B49","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.2337\/db14-1127","article-title":"BMP4 and BMP antagonists regulate human white and beige adipogenesis","volume":"64","author":"Gustafson","year":"2015","journal-title":"Diabetes."},{"issue":"10","key":"2022012016251089600_B50","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/oby.21571","article-title":"Bone morphogenetic protein 2 (BMP2) may contribute to partition of energy storage into visceral and subcutaneous fat depots","volume":"24","author":"Guiu-Jurado","year":"2016","journal-title":"Obesity (Silver Spring)."},{"issue":"7","key":"2022012016251089600_B51","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2337\/db11-1753","article-title":"Intrinsic differences in adipocyte precursor cells from different white fat depots","volume":"61","author":"Macotela","year":"2012","journal-title":"Diabetes."},{"issue":"12","key":"2022012016251089600_B52","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1038\/s41366-019-0421-1","article-title":"Bone morphogenetic protein 2 is a depot-specific regulator of human adipogenesis","volume":"43","author":"Denton","year":"2019","journal-title":"Int J Obes."},{"issue":"7","key":"2022012016251089600_B53","doi-asserted-by":"crossref","first-page":"8666","DOI":"10.1096\/fj.201900520R","article-title":"Myonectin deletion promotes adipose fat storage and reduces liver steatosis","volume":"33","author":"Little","year":"2019","journal-title":"FASEB J."},{"issue":"3","key":"2022012016251089600_B54","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1359\/JBMR.0301249","article-title":"Transcriptional regulation of a BMP-6 promoter by estrogen receptor alpha","volume":"19","author":"Ong","year":"2004","journal-title":"J Bone Miner Res."},{"issue":"1","key":"2022012016251089600_B55","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1210\/me.2002-0210","article-title":"Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells","volume":"17","author":"Zhou","year":"2003","journal-title":"Mol Endocrinol."},{"issue":"1","key":"2022012016251089600_B56","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.crad.2005.07.006","article-title":"The radiological appearances of thalassaemia","volume":"61","author":"Tyler","year":"2006","journal-title":"Clin Radiol."},{"issue":"5","key":"2022012016251089600_B57","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1210\/en.2002-220918","article-title":"Skeletal overexpression of noggin results in osteopenia and reduced bone formation","volume":"144","author":"Devlin","year":"2003","journal-title":"Endocrinology."},{"issue":"2","key":"2022012016251089600_B58","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1210\/en.2004-0766","article-title":"Skeletal overexpression of gremlin impairs bone formation and causes osteopenia","volume":"146","author":"Gazzerro","year":"2005","journal-title":"Endocrinology."},{"key":"2022012016251089600_B59","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1182\/blood-2019-125822","article-title":"Erythroferrone regulates bone remodeling in \u03b2-thalassemia","volume":"134","author":"Castro-Mollo","year":"2019","journal-title":"Blood."},{"issue":"1","key":"2022012016251089600_B60","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/16078454.2019.1599096","article-title":"Beta-thalassemia: renal complications and mechanisms: a narrative review","volume":"24","author":"Demosthenous","year":"2019","journal-title":"Hematology."},{"issue":"6","key":"2022012016251089600_B61","doi-asserted-by":"crossref","first-page":"F1060","DOI":"10.1152\/ajprenal.00191.2002","article-title":"Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models","volume":"285","author":"Zeisberg","year":"2003","journal-title":"Am J Physiol Renal Physiol."},{"issue":"1","key":"2022012016251089600_B62","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1172\/JCI25445","article-title":"Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury","volume":"116","author":"Yanagita","year":"2006","journal-title":"J Clin Invest."},{"issue":"6","key":"2022012016251089600_B63","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/gim.2016.173","article-title":"\u03b2-Thalassemia","volume":"19","author":"Origa","year":"2017","journal-title":"Genet Med."},{"issue":"1","key":"2022012016251089600_B64","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1182\/asheducation-2018.1.353","article-title":"Potential new approaches to the management of the Hb Bart\u2019s hydrops fetalis syndrome: the most severe form of \u03b1-thalassemia","volume":"2018","author":"King","year":"2018","journal-title":"Hematology (Am Soc Hematol Educ Program)."},{"issue":"11","key":"2022012016251089600_B65","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1182\/blood.2019000945","article-title":"Management of pyruvate kinase deficiency in children and adults","volume":"136","author":"Grace","year":"2020","journal-title":"Blood."},{"issue":"11","key":"2022012016251089600_B66","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1182\/blood.2019000948","article-title":"Congenital dyserythropoietic anemias","volume":"136","author":"Iolascon","year":"2020","journal-title":"Blood."},{"issue":"10","key":"2022012016251089600_B67","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood-2016-08-697110","article-title":"An international registry of survivors with Hb Bart\u2019s hydrops fetalis syndrome","volume":"129","author":"Songdej","year":"2017","journal-title":"Blood."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/139\/3\/439\/1861268\/bloodbld2021014054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/139\/3\/439\/1861268\/bloodbld2021014054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T01:11:41Z","timestamp":1673399501000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/139\/3\/439\/477186\/Erythroid-overproduction-of-erythroferrone-causes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,1,20]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2021014054","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.01.09.426054","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,20]]}}}